| Literature DB >> 32520718 |
Mirjam Pot1, Theo Gwm Paulussen1, Robert Ac Ruiter2, Liesbeth Mollema3, Miranda Hofstra1, Hilde M Van Keulen1.
Abstract
BACKGROUND: In the Netherlands, human papillomavirus (HPV) vaccination uptake remains low. To improve informed decision making (IDM) and HPV vaccination acceptability, we systematically developed an interactive, web-based tailored intervention to which mothers of Dutch girls were invited to participate.Entities:
Keywords: HPV vaccination; dose-response relationship; informed decision making; intervention use; process evaluation; randomized controlled trial; web-based tailored intervention
Mesh:
Year: 2020 PMID: 32520718 PMCID: PMC7395256 DOI: 10.2196/14822
Source DB: PubMed Journal: J Med Internet Res ISSN: 1438-8871 Impact factor: 5.428
Brief description of intervention components.
| Menu and component | Description | |
|
|
| |
|
| General information | Mothers are provided with general information about HPV, cervical cancer, and HPV vaccination. |
|
| Importance of vaccinating at a young age | Mothers are challenged to consider whether the age of their daughter is appropriate to get vaccinated against HPV. The relationship between sexual activity in relation to the HPV vaccine is also discussed. |
|
| HPV-related risks | Mothers are asked to estimate both the risk of their daughter getting infected with HPV and the risk of their daughter developing cervical cancer later in life, and are then provided with tailored feedback accordingly. |
|
| Methods to protect against cervical cancer | Mothers are asked to rate the effectiveness of alternative methods for protecting against cervical cancer and are then provided with tailored feedback according to their answers. |
|
| From HPV to cervical cancer | Mothers are provided with an explanation of how infection with HPV can lead to cervical cancer (eg, by viewing an educational video). |
|
| Facts and stories | Mothers are provided with several statements regarding HPV, cervical cancer, and HPV vaccination, and are asked to indicate whether these are true (a fact) or false (a story). They then receive tailored feedback accordingly. |
|
| Side effects | Mothers are presented with a variety of potential side effects of the HPV vaccine and are asked to indicate whether or not they are scientifically proven. They are then provided with tailored feedback, stating the correct responses. |
|
| Effectiveness | Mothers are asked about the effectiveness of the HPV vaccine in protecting both against their daughter getting infected with HPV and developing cervical cancer. They are then provided with tailored feedback about the effectiveness of HPV vaccination. |
|
| Other mothers | Mothers are asked to indicate what they think most mothers in their direct environment will decide regarding their daughters’ HPV vaccination. They are then provided with tailored feedback and are shown the actual HPV vaccination uptake in different regions of the Netherlands in 2014. |
|
| Vaccine working mechanisms | Mothers are explained in a generic way how the HPV vaccine works in protecting against HPV and cervical cancer with an educational video. |
|
|
| |
|
| Decisional balance | Mothers are presented with a list of pros and cons of HPV vaccination. Based on pros and cons mothers marked as most salient, a decisional balance reveals their current position on a scale ranging between wanting and not wanting to get their daughter vaccinated. |
|
| Value clarification | Mothers are invited to list their central values for life and link these to HPV vaccination. |
| Practical information | Practical information provides mothers with information such as how and where to receive the HPV vaccine and provides them with advice on how they discuss HPV vaccination with personal important others (eg, their daughter and partner). | |
|
|
| |
|
| About HPV vaccination | Frequently asked questions provides answers to known questions about the HPV vaccine (eg, “does my daughter know if she’s infected with HPV?”) or getting the HPV vaccine (eg, “where do I get the HPV vaccine?”). |
|
| Problems with the website | Mothers are provided with possible solutions to problems with the website such as not being able to hear or see the virtual assistants. |
aHPV: human papillomavirus.
Overview of the program acceptability measures for the website.
| Measures | Items | Score and scale | Cronbach α or Pearson | Reference |
| Rate | On average, how would you rate the website on a scale from 0 to 10? | 0=very bad to | N/Aa | [ |
| Interest | In general, what did you think of the website? | 1=very uninteresting to | 0.84 ( | [ |
| Informative | In general, what did you think of the website? | 1=very uninformative to 7=very informative; 1=very noneducational to 7 =very educational | 0.86 ( | [ |
| Perceived user control | I felt that I had a lot of control over my visiting experiences at this website. | 1=strongly disagree to 7=strongly agree | .71 ( | [ |
| Elaboration | How well did you read the information? | 1=not carefully at all to 7=very carefully | N/A | [ |
| Support | The website has helped me decide about my daughter’s HPVb vaccination. | 1=strongly disagree to 7=strongly agree | N/A | [ |
| Recall | I can recall the information from the website. | 1=strongly disagree to 7=strongly agree | N/A | [ |
| Personal relevance | I considered the website to be personally relevant. | 1=strongly disagree to 7=strongly agree | N/A | [ |
| Tailoring | I considered the information on the website to be… | 1=not tailored to me at all to 7=very tailored to me | N/A | [ |
| Comprehensibility | I considered the information on the website to be… | 1=not at all understandable to 7=very understandable | N/A | [ |
| Reliability | I considered the information on the website to be… | 1=very unreliable to 7=very reliable | N/A | [ |
| Credibility | I considered the information on the website to be… | 1=very incredible to 7=very credible | N/A | [ |
| Usefulness | I considered the information on the website to be… | 1=very useless to 7=very useful | N/A | [ |
| Readability | I considered the information on the website to be… | 1=very unreadable to 7=very readable | N/A | [ |
| Sidedness | I considered the information on the website to be… | 1=focused on the cons to 7=focused on the pros | N/A | [ |
| Enjoyment | I considered the information on the website to be… | 1=very unenjoyable to 7=very enjoyable | N/A | [ |
| Novelty | The website contained new information for me. | 1=strongly disagree to 7=strongly agree | N/A | [ |
| Attitude toward website | How good or bad did you find… | 1=very bad to 7=very good | .81 ( | [ |
aN/A: not applicable.
bHPV: human papillomavirus.
Overview of the program acceptability measures for the virtual assistants.
| Measures | Items | Score and scale | Pearson | Reference |
| Overall rating | On a scale from 0 to 10, how would you rate: | 0=very bad to 10=excellent | 0.94 | [ |
| Enjoyment | I considered the virtual assistants to be… | 1=very unenjoyable to 7=very enjoyable | N/Aa | [ |
| Reliability | I considered the virtual assistants to be… | 1=very unreliable to 7=very reliable | N/A | [ |
| Credibility | I considered the virtual assistants to be… | 1=very incredible to 7=very credible | N/A | [ |
| Usefulness | I considered the virtual assistants to be… | 1=very useless to 7=very useful | N/A | [ |
aN/A: not applicable.
Figure 1Flow diagram of the recruitment and response of study participants from the experimental condition. Participants could be excluded based on multiple criteria (eg, male with an invalid age). Therefore, the total number of participants excluded differed from the sum of separate criteria for exclusion.
Sample description of mothers in the intervention group (N=3995).
| Variables | N (% missing) | Valuea | |
| Age in years, mean (SD) | 3995 (0) | 43.70 (4.27) | |
|
| 3991 (0.10) |
| |
|
| The Netherlands |
| 3715 (92.99) |
|
| Other |
| 276 (6.91) |
|
| 3998 (0.18) |
| |
|
| Protestant |
| 753 (18.85) |
|
| Not Protestant |
| 3235 (80.98) |
|
| 3991 (0.10) |
| |
|
| Low |
| 588 (14.72) |
|
| Middle |
| 1736 (43.45) |
|
| High |
| 1660 (41.55) |
|
| 3986 (0.23) |
| |
|
| Yes |
| 2923 (73.17) |
|
| No |
| 1063 (26.60) |
aBy reporting 2 decimal points for the percentages, summing the percentages for each category may differ from 100%.
bHPV: human papillomavirus.
Program use of the various intervention components among those who visited at least one page of the intervention (N=2239).
| Intervention component | Completeda, n (%)b | Partly completedc, n (%) | Not visitedd, n (%) | Visited in-depth informatione, n (%) |
| General Information | 1622 (72.44) | 71 (3.17) | 546 (24.39) | N/Af |
| Ways to Protect against Cervical Cancer | 130 (5.81) | 1841 (82.22) | 268 (11.97) | N/A |
| Chance | 135 (6.03) | 1810 (80.84) | 294 (13.13) | 142 (6.34) |
| From HPVg to Cervical Cancer | 96 (4.29) | 1110 (49.58) | 1033 (46.14) | 298 (13.22) |
| Age | 154 (6.88) | 1568 (70.03) | 517 (23.09) | 160 (7.15) |
| Side Effects | 19 (0.85) | 1686 (75.30) | 534 (23.85) | 299 (13.35) |
| Effectivity | 19 (0.85) | 1542 (68.87) | 678 (30.28) | 339 (15.14) |
| Other Mothers | 1099 (49.08) | 416 (18.58) | 724 (32.34) | N/A |
| Working Mechanisms Vaccination | 94 (4.20) | 1015 (45.33) | 1130 (50.47) | 94 (4.20) |
| Facts and Stories | 95 (4.24) | 1220 (54.49) | 924 (41.27) | 99 (4.42) |
| Weighing Pros and Cons | 615 (27.47) | 911 (40.69) | 713 (31.84) | N/A |
| Value Clarification | 269 (12.01) | 24 (1.07) | 1946 (86.91) | N/A |
| Practical Information | 556 (24.83) | 1147 (51.23) | 536 (23.94) | N/A |
aA component was considered “completed” when mothers visited every page of the component.
bBy reporting 2 decimal points for the percentages, summing the percentages for each category may differ from 100%.
c“Partly completed” indicates that the mothers had seen at least one, but not all pages.
d“Not visited” means that the mothers had not visited any of the component’s pages.
e“Visited in-depth information” was also part of the total completeness, but is depicted separately here to provide a better overall view of the mothers’ interest in this information. When one or more of the links to more in-depth information had been clicked on, the in-depth information was marked as “visited.”
fN/A: not applicable as the component did not contain in-depth information.
gHPV: human papillomavirus.
Mean (SD) and median scores on the program acceptability measures among those who visited at least one page of the intervention (N=2239)a.
| Variable | Website (nmissing=726-734) | Virtual assistants (nmissing=960) | ||
|
| Mean (SD) | Median | Mean (SD) | Median |
| Rate (1-10) | 7.64 (1.39) | 8.00 | 7.41 (1.57) | 8.00 |
| Interest (1-7) | 5.41 (1.05) | 5.50 | N/Ab | N/A |
| Informative (1-7) | 5.67 (1.04) | 6.00 | N/A | N/A |
| Attitude toward website (1-7) | 5.53 (.89) | 6.00 | N/A | N/A |
| Perceived user control (1-7) | 5.26 (.97) | 5.50 | N/A | N/A |
| Elaboration (1-7) | 5.70 (1.14) | 6.00 | N/A | N/A |
| Tailoring (1-7) | 5.22 (1.21) | 5.22 | N/A | N/A |
| Comprehensibility (1-7) | 5.40 (1.70) | 6.00 | N/A | N/A |
| Reliability (1-7) | 5.27 (1.23) | 6.00 | 5.04 (1.09) | 5.00 |
| Credibility (1-7) | 5.35 (1.21) | 6.00 | 5.01 (1.22) | 5.00 |
| Usefulness (1-7) | 5.52 (1.10) | 6.00 | 4.83 (1.33) | 5.00 |
| Readability (1-7) | 5.71 (1.04) | 6.00 | N/A | N/A |
| Sidedness (1-7) | 4.74 (1.09) | 4.00 | N/A | N/A |
| Enjoyment (1-7) | 4.70 (1.08) | 5.00 | 4.72 (1.37) | 5.00 |
| Novelty (1-7) | 5.11 (1.39) | 5.00 | N/A | N/A |
| Support (1-7) | 4.34 (1.80) | 5.00 | N/A | N/A |
| Recall (1-7) | 5.16 (1.22) | 5.00 | N/A | N/A |
| Personal relevance (1-7) | 4.87 (1.41) | 5.00 | N/A | N/A |
aA higher score represents a higher score on the program acceptability measure.
bN/A: not applicable.
Effects of use on the outcome measures according to intention-to-treat analyses (N=3995).
| Outcomea | Pretest, mean (SD) | Posttest, mean (SD) | Completeness | Time of website use | |||||||
|
|
|
|
| β (SEM) | Cohen ƒ2 or ORb | β (SEM) | Cohen ƒ2 or OR | ||||
|
|
|
|
|
|
|
| |||||
|
| Has received no HPV injection (reference) | N/Ae | 26.67% (1066) | N/A | N/A | N/A | N/A | ||||
|
| Has received one or two HPV injections | N/A | 73.32% (2929) | .004 (.001)f | 1.004 | .003 (.003)g | 1.003 | ||||
|
|
|
|
|
|
|
| |||||
|
| IDMh: Not informed (reference) | 67.31% (2689) | 42.53% (1699) | N/A | N/A | N/A | N/A | ||||
|
| IDM: Informed | 32.69% (1306) | 57.47% (2296) | .014 (.001)f | 1.014 | .021 (.003)f | 1.021 | ||||
|
| IDM: continuous (0-48) | 18.69 (11.21) | 25.85 (12.30) | .087 (.006)f | 0.075 | .122 (.013)f | .027 | ||||
|
| Decisional conflict (1-7) | 4.33 (1.75) | 5.38 (1.36) | .007 (.001)f | 0.043 | .011 (.002)f | .018 | ||||
|
| Intention (1-7) | 5.35 (1.69) | 5.59 (1.87) | .004 (.001)f | 0.014 | .005 (.002)f | .004 | ||||
|
| Attitude (1- 7) | 5.18 (1.45) | 5.37 (1.51) | .005 (.001)f | 0.027 | .007 (.001)f | .010 | ||||
|
| Beliefs (1-7) | 4.19 (.73) | 4.47 (.81) | .004 (.000)f | 0.051 | .005 (.001)f | .016 | ||||
|
| Risk perception; not vaccinated (1-7) | 3.74 (0.98) | 3.77 (1.08) | .002 (.001)f | 0.003 | .002 (.001)i | .001 | ||||
|
| Risk perception; vaccinated (1-7) | 2.77 (1.07) | 2.64 (1.10) | -.003 (.001)f | 0.008 | –.005 (.001)f | .005 | ||||
|
| Anticipated regret (1-5) | 3.71 (1.25) | 3.59 (1.31) | .002 (.001)f | 0.007 | .004 (.001)f | .004 | ||||
|
| Subjective Norm (–20-20) | 5.88 (7.81) | 7.25 (9.20) | .020 (.004)f | 0.009 | .018 (.008)j | .002 | ||||
|
| Habit (1-7) | 4.28 (1.78) | 4.51 (1.83) | .004 (.001)f | 0.011 | .004 (.002)k | .003 | ||||
|
| Relative effectiveness (1-10) | -1.97 (2.22) | -1.35 (2.27) | .013 (.001)f | 0.051 | .016 (.003)f | .015 | ||||
|
| Self-efficacy (1-7) | 6.27 (.73) | 6.29 (.75) | .003 (.000)f | 0.022 | .004 (.001)f | .007 | ||||
|
| Knowledge (–8-8) | 4.40 (2.14) | 5.75 (2.09) | .017 (.001)f | 0.095 | .024 (.002)f | .034 | ||||
aA higher score means a higher outcome (eg, more positive attitude) except for decisional conflict in which a higher score means less decisional conflict.
bOR: odds ratio; OR>1 means the higher the score on a factor, the higher the outcome of IDM and higher chance of the daughter being vaccinated; OR<1 means the higher the score on a factor, the lower outcome of IDM and lower chance of the daughter being vaccinated.
cHPV: human papillomavirus.
dHPV vaccination uptake was not assessed at baseline.
eN/A: not applicable.
fP<.003 (significant; Bonferroni: 0.05/15 factors).
gP=.20.
hIDM: informed decision making.
iP=.14.
jP=.03.
kP=.01.